Loading Events

« All Events

Hybrid Hybrid Event
  • This event has passed.

Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks

April 3 - April 4

Hybrid Hybrid Event
laboratory in the background with large biocontainment boxes

This public workshop will discuss the use of artificial intelligence (AI) and automated laboratories for biotechnology.

The event will be held in-person at the National Academy of Sciences Building in Washington DC from 9:00am-5:00pm over two days (3-4 April 2024). Virtual attendances is available as well.

The workshop will consider opportunities to leverage AI and laboratory automation capabilities for discovery and development and opportunities to prevent the misuse of biotechnology. The workshop will also explore methods and approaches to identify, track, and forecast the domestic and international development of such technologies.

The transdisciplinary event will convene experts across sectors and utilize expertise to highlight recent advances and explore implications for the development and use of these technologies.

The workshop is being organized by a planning committee of the National Academies of Sciences, Engineering, and Medicine under the auspices of the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology

Workshop presentations and discussions will include the following topics:

  • Applications of AI and automated laboratories for biotechnology discovery and development across various applications
  • Opportunities for using AI and automated laboratories to prevent the misuse of biotechnology
  • Methodologies and information for forecasting the development of AI and automated laboratory technologies, and for assessing the technologies’ current and future capability gaps, including approaches for identifying inaccuracies in science and technology materials that might change such assessments
  • Drivers of innovation for AI and automated laboratory technologies, including technical, financial, and policy drivers
  • Methodologies for assessing the costs and benefits of investing or not investing in the development and adoption of such technologies for national security, which could include methods from other fields that can be translated to biotechnology

Please visit the National Academies’ Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks event page to register.


National Academies of Sciences
2101 Constitution Ave NW
Washington, DC 20418 United States
+ Google Map